TUESDAY, Dec. 29, 2020 — Respiratory problems and other factors — not inflammation — may explain why obese people are more likely to have severe COVID-19 and die from it, according to a new study.
Other studies have shown that overweight and obese COVID-19 patients are more likely to be admitted to intensive care, to require mechanical ventilation, and to die. Population-level studies also indicate that countries with higher obesity rates have higher COVID-19 death rates.
Inflammation had been suggested as a possible reason for the link between obesity and severe COVID-19.
“Though definitive reasons for poor COVID-19 outcomes in obesity remain uncertain, patients with obesity are uniquely vulnerable,” said lead author Dr. Ana Mostaghim, who led the study during a residency in internal medicine at Boston Medical Center. “They may have independent risk factors [type-2 diabetes, hypertension and coronary artery disease] for poor outcomes in COVID-19, conditions that are inflammatory and immune-mediated.”
To learn more, she and her colleagues compared outcomes and inflammatory markers in patients hospitalized with COVID-19.
The study looked at patients’ body mass index (BMI), a measure of body fat based on height and weight, and their risk of ICU admission and death.
COVID patients who were severely obese (BMI of 35 or more) were twice as likely to be admitted to the ICU and had four times the risk of death from any cause. Those with a BMI of 30 to 34.9 also had a higher risk for ICU admission but not a significantly higher risk of death, according to the study.
Researchers found that obese patients had mostly lower inflammatory markers on their first two days in the hospital compared to patients who weren’t obese.
“While patients with obesity had worse clinical outcomes than those without obesity in our study, this effect does not appear to be mediated by a higher degree of inflammation,” said Dr. Natasha Hochberg, an associate professor of medicine at Boston University School of Medicine.
“Patients with obesity are at higher risk of fatty liver disease, and greater viral invasion with organ dysfunction may contribute to the increased mortality seen in these patients,” she said in a university news release. “Alternately, patients with obesity may have reduced respiratory reserve.”
The findings were published online Dec. 16 in the journal PLOS ONE.
© 2020 HealthDay. All rights reserved.
Posted: December 2020
Further Support and Information on COVID-19
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022